期刊文献+

二甲双胍通过诱导G1期阻滞抑制骨肉瘤细胞增殖 被引量:4

The inhibition effect of metformin on proliferation in osteosarcoma MG63 cell line by G1 phase blocking
下载PDF
导出
摘要 目的:检测二甲双胍对人骨肉瘤细胞株MG63增殖的影响。方法:不同浓度二甲双胍刺激MG63-MTT法检测细胞体外增殖能力:5mmol/L二甲双胍作用48h,流式细胞术检测MG63细胞周期分布.免疫印迹检测cyclinD1表达以及AMPK、AKT、S6K及s6蛋白磷酸化水平。结果:0~50mmol/L的二甲双胍对MG63细胞增殖的抑制作用,除10mmol/L和20mmol/L两组间外,其他处理组间均表现出显著性差异(P〈0.01)。5mmol/L二甲双胍诱导MG63细胞发生G1期阻滞(P〈0.01),抑制cylinD1、P-S6K1及P-s6表达,促进AMPK和AKT的磷酸化。结论:二甲双胍通过诱导细胞周期G1期阻滞.通过激活AMPK和AKT的磷酸化抑制roTOR通过抑制MG63增殖。 Objective To explore the effect of metformin on proliferation activity in osteosarcoma MG63 cell line. Methods MG63 cells were stimulated by metformin at different concentrations and the proliferation activities were detected by Methyl thiazolyl tetrazolium (MTT) assays. Cell cycle distrtibutions were detected by flow cytometry. After MG63 cells were treated with 5 mM metformin for 48 h, the expression of cyclin D 1 and protein phosphorylation levels of AMPK, AKT, S6K and S6 were detected by western blotting. Results 1 - 50 mmol/L of metformin concentrations in all the groups showed obvious diffenence in proliferation inhibition of MG63 cells, except two groups of 10 mmol/L and 20 mmol/L of concentrations (P 〈 0.01). Metformin at 5 mmol/L concentration induced the blocking of G1 phase of MG63 cells (P 〈 0.01), in inhibiting the expression of cylin D1, P-S6K1 and P-S6, promoting the protein pbospborylation of AMPK, AKT. Conclusion Metformiu inhibites proliferation of MG63 cells by inducing the G1 phase blocking , activating AMPK, AKT protein phosphorylation to inhibite mTOR signa way.
出处 《实用医学杂志》 CAS 北大核心 2014年第2期202-204,共3页 The Journal of Practical Medicine
基金 国家自然科学基金青年项目(编号:81302357) 广东省自然科学基金博士启动项目(编号:S2013040016493)
关键词 二甲双胍 骨肉瘤 增殖 细胞周期 哺乳动物靶蛋白 Metformin Osteosarcoma Cell Proliferation Cell Cycle Mammalian Target of Rapamycin (roTOR)
  • 相关文献

参考文献9

  • 1Biermann JS, Adkins 9, Benjamin R, et al. Bone caneer[J]. J Natl Compr Cane Netw, 2007,5(4) :420-437.
  • 2Demetri GD, Baker LH, Benjamin RS, et al. Soft tissue sarcoma [J]. J Natl Compr Canc Netw, 2007,5(4) :364-399.
  • 3Friedrich P, Ortiz R, Strait K, etal. Pediatric sarcoma in Central America: outcomes, challenges, and plans for improvement [J]. Cancer, 2013,119(4) :871-879.
  • 4Deng XS, Wang S, Deng A, et al. Metformin targets Star3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers [J]. Cell Cycle, 2012, 11 (2) :367-376.
  • 5Bao B, Wang Z, Ali S, et al. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells [J]. Cancer Prey Res (Phila), 2012,5(3):355-364.
  • 6Tseng CH. Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan [J]. Eur J Endocrinol, 2012,167(3) :409-416.
  • 7Hadad SM, Fleming S, Thompson AM. Targeting AMPK: a new therapeutic opportunity in breast cancer [J]. Crit Rev Oncol Hematol, 2008,67( 1 ) : 1-7.
  • 8Capano M, Crompton M. Bax translocates to mitochondria of heart cells during simulated ischaemia: involvement of AMP- activated and p38 mitogen-activated protein kinases [J]. Biochem J, 2006,395 ( 1 ) : 57-64.
  • 9Khurana A, Shridhar V. Metformin is synthetically lethal with glucose withdrawal in cancer cells [J]. Cell Cycle, 2012,11 (15) : 2779-2780.

同被引文献18

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部